paper-with-me

홈 › Papers

CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons

2023-02-08 · Nature Communications 2023 2 · cite Wu GH, Smith-Geater C, Galaz-Montoya JG, Gu Y, Gupte SR, Aviner R, Mitchell PG, Hsu J, Miramontes R, Wang KQ, Geller NR, Hou C, Danita C, Joubert LM, Schmid MF, Yeung S, Frydman J, Mobley W, Wu C, Thompson LM, Chiu W.

Huntington’s disease (HD) is caused by an expanded CAG repeat in the huntingtin gene, yielding a Huntingtin protein with an expanded polyglutamine tract. While experiments with patient-derived induced pluripotent stem cells (iPSCs) can help understand disease, defining pathological biomarkers remains challenging. Here, we used cryogenic electron tomography to visualize neurites in HD patient iPSC-derived neurons with varying CAG repeats, and primary cortical neurons from BACHD, deltaN17-BACHD, and wild-type mice. In HD models, we discovered sheet aggregates in double membrane-bound organelles, and mitochondria with distorted cristae and enlarged granules, likely mitochondrial RNA granules. We used artificial intelligence to quantify mitochondrial granules, and proteomics experiments reveal differential protein content in isolated HD mitochondria. Knockdown of Protein Inhibitor of Activated STAT1 ameliorated aberrant phenotypes in iPSC- and BACHD neurons. We show that integrated ultrastructural and proteomic approaches may uncover early HD phenotypes to accelerate diagnostics and the development of targeted therapeutics for HD.

📄 PDF Abstract BibTeX

Code (0)

등록된 구현이 없습니다.

Tasks

Cryogenic Electron TomographyElectron Tomography

Methods 이 논문이 사용한 방법론

Heatmap 설명 없음
CAG Class activation guide is a module which uses weak localization information from the instrument activation maps to guide the verb and target recognition. Image source: [Nwoye…

Similar Papers 제목 키워드 기반

Vocal markers from sustained phonation in Huntington's Disease

2020-06-09 · Rachid Riad, Hadrien Titeux, Laurie Lemoine, Justine Montillot 외

Disease-modifying treatments are currently assessed in neurodegenerative diseases. Huntington's Disease represents a unique opportunity to design automatic sub-clinical markers, even in premanifest gene carriers. We inve…

regression

Explaining Unsupervised Disease Staging in Huntington's Disease: Insights into Model Representations and Clusters

2026-06-05 · Lubna Mahmoud Abu Zohair, Hind Zantout arxiv

Huntington's disease (HD) is a progressive neurodegenerative disorder that affects motor, cognitive, and behavioral functions, where accurate characterization of disease progression remains essential to improve patient o…

Feature Importance

Multi-Agent Reasoning for Cardiovascular Imaging Phenotype Analysis

2025-07-04 · Weitong Zhang, Mengyun Qiao, Chengqi Zang, Steven Niederer 외 arxiv

Identifying associations between imaging phenotypes, disease risk factors, and clinical outcomes is essential for understanding disease mechanisms. However, traditional approaches rely on human-driven hypothesis testing …

Tensor-Based Grading: A Novel Patch-Based Grading Approach for the Analysis of Deformation Fields in Huntington's Disease

2020-01-23 · Kilian Hett, Hans Johnson, Pierrick Coupé, Jane Paulsen 외

The improvements in magnetic resonance imaging have led to the development of numerous techniques to better detect structural alterations caused by neurodegenerative diseases. Among these, the patch-based grading framewo…

General Classification

Classification of Huntington Disease using Acoustic and Lexical Features

2020-08-07 · Matthew Perez, Wenyu Jin, Duc Le, Noelle Carlozzi 외

Speech is a critical biomarker for Huntington Disease (HD), with changes in speech increasing in severity as the disease progresses. Speech analyses are currently conducted using either transcriptions created manually by…

ClassificationGeneral Classification